Month: September 2014

¿LA EVALUACIÓN DE INSUMOS, IMPACTA EN LA OPTIMIZACIÓN DE RECURSOS?

México, D.F. – En México, se fortaleció el proceso de actualización de medicamentos del  Cuadro Básico y Catálogo de Insumos del Sector Salud (CBCISS), estandarizando criterios de selección, basados en evidencia clínica-epidemiológica-económica. 

Posted in Health Policy Analyses, Value in Health Regional Issues Tagged with: , ,

IS SUFFICIENT DATA AVAILABLE TO MEET HEALTH-ECONOMIC REQUIREMENTS ACROSS EUROPE?

Prague, Czech Republic – Many Central & Eastern European (CEE) countries have recently introduced mandatory health economic (HE) evaluations to grant reimbursements for medical technologies. Health economic requirements in the CEE countries are often aligned to Western European standards, mainly

Posted in Health Policy Analyses, Value in Health Regional Issues Tagged with: , , ,

HEALTH CARE REFORMS AND ACCESS TO MEDICINES IN ETHIOPIA

Addis Ababa, Ethiopia – The Ethiopian health care system is under tremendous reform. One of the top issues on the agenda is health care financing. In an effort to protect citizens from the catastrophic effects of the high share of

Posted in Health Policy Analyses, Value in Health Regional Issues Tagged with: ,

THE INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS AND OUTCOMES RESEARCH ANNOUNCES NEW CEO AND EXECUTIVE DIRECTOR

Princeton, New Jersey, September 16, 2014 – The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is pleased to announce that Nancy S. Berg will join the Society on October 22, 2014, as its CEO and Executive Director, succeeding ISPOR

Posted in Announcements, ISPOR News & Press Tagged with: